Manish Kohli

Liquid biopsy and nanotechnology enthusiast for changing cancer practice.

[Manish Kohli @KohliMask1020]

Cost-Effectiveness Analysis of seven treatments In Metastatic Hormone-Sensitive Prostate Cancer (mHSPC): A Public-Payer Perspective https://t.co/nkc3pYCoEQ - In the background of a lack of predictive biomarkers and head-to-head comparisons

[Manish Kohli @KohliMask1020]

Cancer heterogeneity at the molecular level evolves continuously and, in most cases, ferociously from local to metastatic states. Machine-Learning #ML application successfully captures a molecular signature in blood that is based on a set of genomic (#ctD…https://t.co/F86idi0HD0

[Manish Kohli @KohliMask1020]

Privileged to visit and present at the #CanaryCenter at #stanforduniversity "Early Detection Seminar Series" and foster current and future research collaborations between #huntsmancancerinstitute, #universityofutah and #stanforduniversity . Fantastic po…https://t.co/Zr1r2IXkiz

[Manish Kohli @KohliMask1020]

Dearth of molecular predictive/prognostic bio markers in metastatic hormone-sensitive prostate cancer (mHSPC) is an existential challenge in the clinics. In a joint collaborative effort between #HuntsmanCancerInstitute at #universityofutah and #MoffittCa…https://t.co/G6xqHMaydB

[Manish Kohli @KohliMask1020]

The value of fusing clinically useful genomic tumor-specific, state-relevant molecules with emerging ultra sensitive technologies (Quantum Dots) potentially enhances multiplexing capacities using qPCR for cancer care in future. Presented at #aacr2023 as a…https://t.co/VXDauwITWP

[Manish Kohli @KohliMask1020]

Excellent portal of high quality educational series and discussions on myeloma!! https://t.co/T4uyygRk93

[Manish Kohli @KohliMask1020]

With so many first line FDA approved (costly) treatments available for patients with kidney cancer that has spread, there is considerable confusion amongst cancer experts on choosing one over the other.

There are no clear validat…https://t.co/dQHyOpRph5 https://t.co/QKwYOB5HhK

[Manish Kohli @KohliMask1020]

Our team published a plasma Copy Number Alteration (CNA)-Based Prognostic and Predictive Multi-Gene Risk Scores in Metastatic Castration-Resistant Prostate Cancer using two independent cohorts. Ability to predict clinical outcomes…https://t.co/e8XVCh1k0d https://t.co/4VLW2wXert

[Manish Kohli @KohliMask1020]

Starting work on my 5th NIH funded RO1 in #cancerresearch - this time working on a different theme with gifted colleagues at U of Utah/Huntsman Cancer Institute, U. Michigan and Fred Hutch and on a theme to improve detection of cancer recurrences in #pro…https://t.co/lq4RVZmT5S

[Manish Kohli @KohliMask1020]

@KLM I replied

[Manish Kohli @KohliMask1020]

Stuck at BHX with technical fault in plane; multiple missed connections; no customer service or updates on when we can get back home. It has been over 7 hours. Shabby job @KLM @Delta!

[Arun Azad @AzadOncology]

Our @ASCO_pubs #JCOPO paper on prognostic utility of PI3K and AR pathway aberrations in #ProstateCancer #LiquidBiopsy is out today! Congrats to @EdmondMKwan for leading a team of amazing collaborators https://t.co/hK7ViS7IwC 🧵1/8

[Manish Kohli @KohliMask1020]

@itsnot_pink Yes- the “luck” factor is still relevant as there is so much we still need to know at the individual pt level in order to prescribe/ treat/manage. Hope researchers keep working on how to peel down the unknown more and treat in an even more smarter way!

[Neeraj Agarwal, MD, FASCO @neerajaiims]

#GU21 @ASCO Very proud to see my dear friend Dr. Jonathan Tward @prostatemd @huntsmancancer @Huntsman_GU giving this excellent talk 👉Prolaris test may allow some pts with localized @prostatecancer avoid androgen deprivation Rx. Must watch @DrPaulNguyen @OncoAlert @PCF_Science

[Manish Kohli @KohliMask1020]

@InadomiJ @mzmolnar @neerajaiims @KenGrossmannMD @SiwenONC @umangtalking @maughanonc @EAMiddleton5 @RondinaLab Energetic and passionate gp @ U of U- HCI

[John Inadomi @InadomiJ]

(2/2) @mzmolnar @KohliMask1020 @neerajaiims @KenGrossmannMD @SiwenONC @umangtalking @maughanonc @EAMiddleton5 @RondinaLab and any others I may have missed or are not a part of the Twitter-sphere. #MedicineElevated #ResearchElevated

[Manish Kohli @KohliMask1020]

@NicoleKuderer @neerajaiims @OncoAlert @NeliMUlrich @DrChoueiri @montypal @PGrivasMDPhD @VivekSubbiah @ADesaiMD @umangtalking @cdanicas @GGiannarini @gary_lyman Hi Nicole- Hope all has been well with you/Gary! (still learning twitter- apologies for the late replay); would love to see you here in Utah as Neli mentioned! Best regards!

[Manish Kohli @KohliMask1020]

The Identification of Plasma Exosomal miR-423-3p as a Potential Predictive Biomarker for Prostate Cancer Castration… https://t.co/HdnzTx0dlh
Pleasure to participate in this international collaboration! Additional evidence of the clinical value miRs in mCRPC!

[Manish Kohli @KohliMask1020]

https://t.co/45wFbRKbAV via @MDPIOpenAccess We observed that plasma progastrin (hPG80) is detected in 94% of mRCCC patients and hPG80 levels significantly enhance the prognostic performance of IMDC in mRCCC. Need more prospective validation

[Neeraj Agarwal, MD, FASCO @neerajaiims]

Must read in @JCO_ASCO today-> brilliant insights on the biology underneath differential efficacy of PARP inhibitors in #prostatecancer with BRCA1 vs. BRCA2 mutations 👇by @EAntonarakis @MarkowskiGUOnc @HopkinsMedicine Weblink👉🏻 https://t.co/Xq2yQZBf5C @OncoAlert @urotoday